Bornschein W
Z Gastroenterol. 1985 May;23(5):247-56.
To obtain higher specificity of peptide-PABA-test, an indirect pancreatic functions test, 150 mg N-BT-PABA together with 25 g D-Xylose in 300 ml tea were administered to a group of 68 persons. Maximal concentration of PABA and D-Xylose were investigated serum by time-concentration-curves 0, 60, 90, 120 and 150 min after test meal. Serum-PABA was found pathologically low in 18 of 20 patients with proofed chronic pancreatitis. In 16 of 17 patients with chronic pancreatitis serum-D-Xylose was normal. In a group of 39 patients, in which a pancreatic disease was excluded, PABA-serum-test showed no false-pathological results. In 7 patients with small-bowel diseases and pathological D-Xylose-test, PABA-serum-test was false-pathologically in 6/7 cases. By serum-PABA-time-concentration-curves there was a significant discrimination between patients with chronic pancreatitis and controls at 60, 90, 120 and 150 min (p less than 0.01), but early and late peak concentration of PABA was often found in the two groups. If the PABA-concentration was estimated only 120 min after test meal, diminished test-specificity was found. Peak-PABA-serum-concentration was significantly correlated with lipase output (p less than 0.001) and trypsin output (p = 0.01) at secretin-caerulein test, but PABA was only at low enzyme outputs pathological, showing a moderate sensitivity of test.
为了提高肽-对氨基苯甲酸试验(一种间接胰腺功能试验)的特异性,将150毫克N-苯甲酰-L-酪氨酸对氨基苯甲酸与25克D-木糖溶于300毫升茶中,给予68人组成的一组人群。在试餐后0、60、90、120和150分钟,通过时间-浓度曲线研究血清中对氨基苯甲酸和D-木糖的最大浓度。在20例经证实的慢性胰腺炎患者中,有18例血清对氨基苯甲酸水平病理性降低。在17例慢性胰腺炎患者中,有16例血清D-木糖水平正常。在一组排除胰腺疾病的39例患者中,血清对氨基苯甲酸试验未出现假阳性结果。在7例患有小肠疾病且D-木糖试验结果异常的患者中,血清对氨基苯甲酸试验在6/7的病例中出现假阳性。通过血清对氨基苯甲酸-时间-浓度曲线,在60、90、120和150分钟时,慢性胰腺炎患者与对照组之间存在显著差异(p<0.01),但两组中对氨基苯甲酸的早期和晚期峰值浓度经常出现。如果仅在试餐后120分钟评估对氨基苯甲酸浓度,则会发现试验特异性降低。在促胰液素-雨蛙肽试验中,血清对氨基苯甲酸峰值浓度与脂肪酶分泌量(p<0.001)和胰蛋白酶分泌量(p = 0.01)显著相关,但只有在酶分泌量较低时对氨基苯甲酸才呈病理性,表明该试验具有中等敏感性。